All Articles

A junior miner is drilling deep into BC, chasing a geological theory that could unearth the legendary hard rock source of historic placer gold.

A routine share listing by Next 15 reveals a deeper strategy. Discover how the tech consultancy uses equity to retain top talent and drive growth.

A new partnership aims to fast-track a novel green hydrogen generator, unlocking autonomous power for remote industries and challenging fossil fuel logistics.

A high-grade silver discovery in a historic Idaho mining camp gets a strategic boost from significant antimony, a critical mineral vital for defense.

Enveric Biosciences heads to J.P. Morgan Week to pitch its novel non-hallucinogenic neuroplastogens. Can it secure the deals to disrupt mental health?

CIMG Inc. just won a "Most Investable" award, but a look under the hood reveals a company grappling with cash burn and a risky crypto strategy.

Uzbekistan's new Islamic Civilization Center has won a top prize, signaling a new era of cultural diplomacy and a revival of Golden Age science.

U.S. healthcare tech faces a talent crisis. The solution may lie in an unexpected place: a booming freelance market in Poland and Eastern Europe.

A surge in demand for an all-in-one dog walking kit reveals a deeper trend: how brands are using strategic design to win in the booming pet market.

A pivotal FDA meeting may have put Atossa Therapeutics' novel breast cancer drug, (Z)-endoxifen, on an accelerated path, a strategic win for investors.

Camping World's latest dividend signals stability, but a deeper look reveals a complex strategy to navigate RV market headwinds and capitalize on new trends.

For the seventh year, Greif tops a key responsibility list. We explore how the packaging giant turned ESG consistency into a powerful business advantage.

Beyond 200,000 houses, Meritage Homes' focus on energy efficiency and affordability is laying the foundational infrastructure for our connected future.

Volatus Aerospace appoints a top retired general, a strategic play to capture a share of Canada's multi-billion-dollar defense and NORAD modernization.

Reeling from a trial failure, Neuphoria Therapeutics battles an activist's lowball bid while its board scrambles to unlock hidden value in a high-stakes review.

A novel drug aims to replace toxic chemo and conquer aggressive breast cancer. Can Intensity Therapeutics' direct tumor injection shift the treatment paradigm?

An AWS award for Smarsh signals a seismic shift in financial compliance. Discover how AI and the cloud are rewriting the rules for risk management.

An Israeli biotech's manufacturing milestone isn't just a production win; it's a strategic move to commercialize its nasal shield technology.

Cambridge biotech Atavistik Bio reveals a novel allosteric inhibitor targeting a key MPN mutation, promising disease modification without current side effects.

A new survey finds social service workers optimistic about automation, but can technology truly fix a system plagued by staff shortages and policy hurdles?